Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing
- PMID: 27255578
- DOI: 10.1016/j.jhep.2016.04.033
Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing
Comment in
-
Reply to "Direct antiviral agents and risk for hepatocellular carcinoma (HCC) early recurrence: Much ado about nothing".J Hepatol. 2016 Oct;65(4):864-865. doi: 10.1016/j.jhep.2016.05.036. Epub 2016 May 30. J Hepatol. 2016. PMID: 27255581 No abstract available.
Comment on
-
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy.J Hepatol. 2016 Oct;65(4):719-726. doi: 10.1016/j.jhep.2016.04.008. Epub 2016 Apr 13. J Hepatol. 2016. PMID: 27084592
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources